Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Oncology Reports
|
October 2, 2015
Immunotherapy in Sarcoma: Future Horizons
Melissa Burgess, Vikram Gorantla, Kurt Weiss, et al.
Current Oncology Reports
|
August 20, 2013
Melanoma brain metastases: an unmet challenge in the era of active therapy
Vikram Gorantla, John M Kirkwood, Hussein A Tawbi
Journal for Immunotherapy of Cancer
|
September 2, 2018
Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
Christine A Garcia, Alex El-Ali, Tanya J Rath, et al.
JCO Oncology Practice
|
March 2, 2023
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future
Ibrahim Halil Sahin, Janie Zhang, Turcin Saridogan, et al.
Breast Cancer Research and Treatment
|
December 16, 2022
Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network
Hayeon Kim, Hong Wang, Kathryn Demanelis, et al.
JCO Oncology Practice
|
May 13, 2024
Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine
Ibrahim Halil Sahin, Turcin Saridogan, Ruveyda Ayasun, et al.
The Oncologist
|
July 31, 2025
Investigating incidence of RAS/RAF and PIK3CA alterations in HER2-amplified colorectal cancer: a comprehensive analysis
Svea Cheng, Cyndi Gonzales Gomez, Morgan Ferrell, et al.
Technology in Cancer Research & Treatment
|
January 27, 2025
Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer
Rami Yanes, Turcin Saridogan, Vikram Gorantla, et al.
JCO Oncology Practice
|
March 19, 2025
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced Cancer: A Randomized Clinical Trial
Yael Schenker, Shane C Belin, Tianxiu Wang, et al.
NPJ Precision Oncology
|
February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer
Ibrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Oncology Reports
|
October 2, 2015
Immunotherapy in Sarcoma: Future Horizons
Melissa Burgess, Vikram Gorantla, Kurt Weiss, et al.
Current Oncology Reports
|
August 20, 2013
Melanoma brain metastases: an unmet challenge in the era of active therapy
Vikram Gorantla, John M Kirkwood, Hussein A Tawbi
Journal for Immunotherapy of Cancer
|
September 2, 2018
Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
Christine A Garcia, Alex El-Ali, Tanya J Rath, et al.
JCO Oncology Practice
|
March 2, 2023
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future
Ibrahim Halil Sahin, Janie Zhang, Turcin Saridogan, et al.
Breast Cancer Research and Treatment
|
December 16, 2022
Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network
Hayeon Kim, Hong Wang, Kathryn Demanelis, et al.
JCO Oncology Practice
|
May 13, 2024
Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine
Ibrahim Halil Sahin, Turcin Saridogan, Ruveyda Ayasun, et al.
The Oncologist
|
July 31, 2025
Investigating incidence of RAS/RAF and PIK3CA alterations in HER2-amplified colorectal cancer: a comprehensive analysis
Svea Cheng, Cyndi Gonzales Gomez, Morgan Ferrell, et al.
Technology in Cancer Research & Treatment
|
January 27, 2025
Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer
Rami Yanes, Turcin Saridogan, Vikram Gorantla, et al.
JCO Oncology Practice
|
March 19, 2025
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced Cancer: A Randomized Clinical Trial
Yael Schenker, Shane C Belin, Tianxiu Wang, et al.
NPJ Precision Oncology
|
February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer
Ibrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.
Page
of 2